Trials / Completed
CompletedNCT02217579
Effect of Protein and Prebiotic Fiber Intake on Adiposity in Overweight and Obese Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 132 (actual)
- Sponsor
- University of Calgary · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The metabolic syndrome is rising worldwide as a consequence of the continued obesity epidemic. The current obesogenic environment makes the regulation of energy intake difficult and impedes the maintenance of weight loss. Dietary patterns and/or ingredients that curb hunger and reduce energy intake are critically needed. We hypothesize that inclusion of protein and prebiotic fiber in the diet will reduce adiposity in overweight and obesity adults.
Detailed description
The main objective of our study is to assess the effects of protein and prebiotic fiber intake on changes in adiposity in an overweight and obese adult population. Primary objective - To determine the effect of 12 week protein (10 g/day) or prebiotic fiber (16 g/day) intake on changes in body composition, chiefly body fat. Secondary objective - To measure changes in appetite following 12 weeks of protein (10 g/day) or prebiotic fiber (16 g/day) intake. Other outcomes includes changes in quality of life ratings and gut microbiota.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Protein | A food containing 5 grams/serving of supplemental protein. |
| DIETARY_SUPPLEMENT | Prebiotic fiber | A food containing 8 grams/serving of supplemental prebiotic fiber. |
| DIETARY_SUPPLEMENT | Protein plus prebiotic fiber | A food containing supplemental protein (5 grams/serving) and prebiotic fiber (8 grams/serving). |
| DIETARY_SUPPLEMENT | Control | An isocaloric food not containing the test protein and fiber. |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-12-01
- Completion
- 2017-08-01
- First posted
- 2014-08-15
- Last updated
- 2017-10-26
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02217579. Inclusion in this directory is not an endorsement.